N. N. Prishchepa

ORCID: 0000-0001-8066-228X
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • Healthcare Systems and Public Health
  • Hip and Femur Fractures
  • Bone health and osteoporosis research
  • Sodium Intake and Health
  • Nutritional Studies and Diet
  • Lipoproteins and Cardiovascular Health
  • Blood Pressure and Hypertension Studies
  • Birth, Development, and Health
  • Chronic Kidney Disease and Diabetes
  • Obesity, Physical Activity, Diet
  • Eating Disorders and Behaviors
  • Diet, Metabolism, and Disease
  • Human Health and Disease
  • Acute Myocardial Infarction Research
  • Renal Diseases and Glomerulopathies
  • Cardiac Imaging and Diagnostics
  • Liver Disease and Transplantation
  • Liver Disease Diagnosis and Treatment

St. Petersburg State Medical Academy "City Polyclinic №44"
2020-2025

Participants of the study ESSE-RF-2 and co-authors: Moscow: Konstantinov V. V., Pokrovskaya M.S., Efimova I.A., Sivakova O.V.; Krasnodar: Alekseenko S.N., Gubarev S.V.; О msk: Livzan M.A., Grishechkina Rozhkova M.Yu.; Republic Karelia: Vezikova N.N., Skopec I. S.; Ryazan: Filippov E.V., Dobrynina N.V., Nikulina Pereverzeva K.G., Moseychuk K.A. Aim. Evaluate prevalence, awareness, treatment, control hypertension among people aged 25-64 examined in 4 regions Russian Federation. Material...

10.20996/1819-6446-2019-15-4-450-466 article EN cc-by Rational Pharmacotherapy in Cardiology 2019-09-02

Aim. To study the prevalence of non-alcoholic fatty liver disease (NAFLD) and its association with cardiovascular risk factors (RFs). Material methods. The database from ESSE-RF2 ESSE-RF3 epidemiological studies was used, including data surveys population aged 35-64 years in 18 Russian regions (n=21204). assess NAFLD, index (FLI) used. Statistical analysis performed using statistical programming language R environment (version 3.6.1) open-source code. significance level for all tested...

10.15829/1728-8800-2025-4316 article EN cc-by CARDIOVASCULAR THERAPY AND PREVENTION 2025-02-08

Aim . To assess the relationship of population’s adherence to a healthy lifestyle (HLS) with socio-demographics and carry out comparative analysis according ESSE-RF-1 ESSE-RF-2 studies. Material methods This study was conducted as part multicenter epidemiological in 4 regions Russia (n=5897). The following components HLS were considered: non-smoking, adequate consumption fruits vegetables, salt intake, regular physical activity, low alcohol consumption. According combination components,...

10.15829/1728-8800-2020-2452 article EN cc-by CARDIOVASCULAR THERAPY AND PREVENTION 2020-04-21

Aim. To assess the prevalence of non-alcoholic fatty liver disease (NAFLD) using obesity index — FLI (Fatty Liver Index), and to study its associations with socio-demographic indicators behavioral risk factors for NAFLD. Material methods . The data from multicenter ESSE-RF (Epidemiology cardiovascular diseases in regions Russian Federation) samples unorganized male female population aged 25-64 years were used. 5,161 respondents included, which 2,275 (44,1%) men. NAFLD, was used, calculated...

10.15829/1728-8800-2022-3356 article EN cc-by CARDIOVASCULAR THERAPY AND PREVENTION 2022-09-12

Aim. To study the prevalence of familial hypercholesterolemia (FH), characteristics clinical features and treatment disease in selected regions Russian Federation, this article describes design initial patients included study. Material methods. The participants were among those “Epidemiology cardiovascular risk factors diseases Federation” (ESSE-RF) different Federation. individuals with lowdensity lipoprotein cholesterol (LDL-C) levels >4.9 mmol/l or LDL-C >1.8 mmol/l, but ≤4.9 during...

10.20996/1819-6446-2020-02-17 article EN Rational Pharmacotherapy in Cardiology 2020-03-02

Aim . To study the association of blood pressure (BP) and hypertension (HTN) with salt intake estimated by survey urinary Na+ concentration among men women 25-64 years old, examined within ESSE-RF ESSE-RF-2 studies. Material methods Representative samples Russian population aged were examined. At first phase in 2012-2014, 21,888 people (men — 38,2%) included, at second 2017 6,714 44,7%). The response rate was 80%. We used standard questionnaire. Adding more consumption salted foods...

10.15829/1560-4071-2020-3791 article EN Russian Journal of Cardiology 2020-07-11

Aim . To study the influence of social determinants on frequency glomerular filtration rate (GFR) categories various levels, as well associations with a number cardiovascular diseases (CVD) and risk factors among population four Russian regions included in ESSE-RF-2. Material methods The was performed part multicenter epidemiological “Epidemiology Federation. second (ESSE-RF-2)”. In total, 6681 people 25-64 years old from 4 Federation were analysis. CKD-EPI formula used to calculate GFR by...

10.20996/1819-6446-2020-04-09 article EN cc-by Rational Pharmacotherapy in Cardiology 2020-04-19

<h3>ЦЕЛЬ ИССЛЕДОВАНИЯ</h3> Изучить распределение средних значений абсолютного риска (АР) остеопорозных переломов (ОПП) и распространенность высокого АР в 4 регионах РФ зависимости от социально-демографических характеристик — возраста, пола места проживания (город или село). <h3>МАТЕРИАЛ И МЕТОДЫ</h3> Исследование проведено на представительных выборках городского сельского населения из регионов РФ: Республика Карелия, Краснодарский край, Рязанская Омская области. При формировании общей...

10.17116/profmed20202305133 article RU Russian Journal of Preventive Medicine 2020-01-01

<h3>ЦЕЛЬ ИССЛЕДОВАНИЯ</h3> Провести анализ взаимосвязей абсолютного риска (АР) остеопорозных переломов (ОПП) с суммарным сердечно-сосудистым риском (ССР) и сердечно-сосудистыми заболеваниями, обусловленными атеросклерозом (ССЗ-АС), среди городского сельского населения РФ. <h3>МАТЕРИАЛ И МЕТОДЫ</h3> В исследование включены представительные выборки (1821 мужчина 2427 женщин в возрасте 40—69 лет) из 4 регионов РФ (Республика Карелия, Краснодарский край, Рязанская Омская области), обследованные...

10.17116/profmed20212406118 article RU Russian Journal of Preventive Medicine 2021-01-01
Coming Soon ...